Medicare Enrolled
Dr. Jill Johnson, M.D.
Rheumatology · Philadelphia, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Johnson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Johnson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Johnson
Dr. Jill Johnson is a rheumatology specialist in Philadelphia, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Johnson performed 50,103 Medicare services across 1,045 unique beneficiaries.
Between the years covered by Open Payments, Dr. Johnson received a total of $14,383 from 44 pharmaceutical and/or device companies across 728 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Johnson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 22% volume in PA
$14,383 industry payments
Medicare Practice Summary
Medicare Utilization ↗50,103
Medicare services
Top 22% in PA for rheumatology
1,045
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,637 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
13,994 | $11 | $30 |
| Tocilizumab injection (Actemra) | 10,472 | $5 | $10 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
9,975 | $34 | $80 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
8,590 | $26 | $135 |
| Denosumab injection (Prolia/Xgeva) | 5,220 | $18 | $30 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
384 | $109 | $500 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
352 | $99 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
197 | $67 | $125 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
186 | $24 | $200 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
161 | $6 | $120 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
121 | $10 | $125 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
96 | $5 | $30 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
72 | $61 | $167 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
70 | $119 | $225 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
68 | $4 | $30 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
66 | $13 | $80 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
33 | $52 | $400 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
25 | $87 | $210 |
| Injection, methylprednisolone acetate, 40 mg | 21 | $5 | $11 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
65.8% high complexity
32.9% medium
1.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,383
Total received (2018-2024)
Avg $2,055/year across 7 years
Top 22% in PA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
728
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,383 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,272
2023
$3,432
2022
$2,663
2021
$1,223
2020
$281
2019
$951
2018
$1,561
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$621
Janssen Biotech, Inc.
$572
UCB, Inc.
$538
ABBVIE INC.
$513
E.R. Squibb & Sons, L.L.C.
$285
AstraZeneca Pharmaceuticals LP
$269
ANI Pharmaceuticals, Inc.
$227
GlaxoSmithKline, LLC.
$225
PFIZER INC.
$181
Mallinckrodt Hospital Products Inc.
$146
Radius Health, Inc.
$137
Novartis Pharmaceuticals Corporation
$89
Boehringer Ingelheim Pharmaceuticals, Inc.
$77
Organon Llc
$49
Fresenius Kabi USA, LLC
$47
Zimmer Biomet Holdings, Inc.
$44
SOBI, INC
$32
GENZYME CORPORATION
$32
Alexion Pharmaceuticals, Inc.
$31
Fidia Pharma USA Inc.
$27
Kyowa Kirin, Inc.
$25
Ultragenyx Pharmaceutical Inc.
$25
DePuy Synthes Sales Inc.
$24
Aurinia Pharma U.S., Inc.
$19
Genentech USA, Inc.
$18
Lilly USA, LLC
$17
Top 3 companies account for 40.5% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,074
Janssen Biotech, Inc.
$1,737
UCB, Inc.
$1,337
PFIZER INC.
$1,206
ABBVIE INC.
$1,179
Novartis Pharmaceuticals Corporation
$798
E.R. Squibb & Sons, L.L.C.
$672
AstraZeneca Pharmaceuticals LP
$617
Genentech USA, Inc.
$502
GlaxoSmithKline, LLC.
$482
ANI Pharmaceuticals, Inc.
$415
Boehringer Ingelheim Pharmaceuticals, Inc.
$401
Mallinckrodt Hospital Products Inc.
$259
AbbVie Inc.
$245
Radius Health, Inc.
$214
Aurinia Pharma U.S., Inc.
$204
GENZYME CORPORATION
$200
AbbVie, Inc.
$196
Lilly USA, LLC
$180
Exeltis, USA Inc.
$164
Alexion Pharmaceuticals, Inc.
$107
Flexion Therapeutics, Inc.
$106
Horizon Therapeutics plc
$98
Mallinckrodt LLC
$86
Zimmer Biomet Holdings, Inc.
$81
DePuy Synthes Sales Inc.
$79
Mallinckrodt Enterprises LLC
$75
Fidia Pharma USA Inc.
$71
Fresenius Kabi USA, LLC
$65
Organon LLC
$63
MEDAC PHARMA, INC.
$53
MEDEXUS PHARMA, INC.
$51
Kyowa Kirin, Inc.
$50
Organon Llc
$49
Ultragenyx Pharmaceutical Inc.
$44
West-Ward Pharmaceuticals
$34
Sobi, Inc
$34
SOBI, INC
$32
Pacira Pharmaceuticals Incorporated
$27
Celgene Corporation
$25
Mylan Institutional Inc.
$22
Orthogenrx Inc.
$19
Ironwood Pharmaceuticals, Inc
$18
Merck Sharp & Dohme Corporation
$13
Top 3 companies account for 35.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUZALLO · EVENITY · Enbrel · FORTEO · Gel-One Cross-linked Hyaluronate · GenVisc 850 · HADLIMA · HUMIRA · HYALGAN · HYMOVIS · Hulio · Humira · IDACIO · INFLECTRA · Iovera · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · ORTHOVISC · Otezla · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Prolia · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tymlos · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
179
Per 100K population
11.3
County median income
$60,698
Nearest hospital
NAZARETH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Johnson is a mixed practice specialist, with above-average Medicare volume (top 22% in PA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Johnson experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Johnson performed 13,994 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Johnson receive payments from pharmaceutical companies?
Yes. Dr. Johnson received a total of $14,383 from 44 companies across 728 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Johnson's costs compare to other rheumatologists in Philadelphia?
Dr. Johnson's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Johnson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Philadelphia
Browse rheumatologists in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in PA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in PA
Which PA rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology